TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2201496

Group type: COMPARATOR
Intervention: Glucose (50 g)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: HSH 6075 (14% sorbitol/78% hydrogenated maltooligosaccharides)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: HSH 5875 (7% sorbitol/60% maltitol)
Number of subjects: 18

Group type: COMPARATOR
Intervention: C-peptide response
Number of subjects: 18

Group type: COMPARATOR
Intervention: Breath H2 after glucose
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Gastric distress
Number of subjects: 18
Study: 7273647

Group type: EXPERIMENTAL
Intervention: TNI
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TNI followed by LOPP
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TNI for patients without splenic involvement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemotherapy (randomised between MOPP and LOPP) for patients with splenic involvement
Number of subjects: 0

Group type: COMPARATOR
Intervention: MOPP
Number of subjects: 0

Group type: COMPARATOR
Intervention: LOPP
Number of subjects: 0
Study: 31935382

Group type: EXPERIMENTAL
Intervention: Transdermal contraceptive patch with newly sourced adhesive component (test)
Number of subjects: 70

Group type: COMPARATOR
Intervention: EVRA patch (reference)
Number of subjects: 70
Study: 30573280

Group type: EXPERIMENTAL
Intervention: Direct stenting (DS)
Number of subjects: 342

Group type: COMPARATOR
Intervention: Conventional stenting (CS)
Number of subjects: 342
Study: 28600161

Group type: EXPERIMENTAL
Intervention: Healthy Living Problem‐Solving (HELPS) intervention consisting of six group sessions conducted approximately monthly interspersed with individualized coaching calls.
Number of subjects: 400

Group type: COMPARATOR
Intervention: Care as usual (control group).
Number of subjects: 400
Study: 25112845

Group type: EXPERIMENTAL
Intervention: 50 mg sulodexide daily for 12 months
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo (matching dose) daily for 12 months
Number of subjects: 130
Study: 24028441

Group type: EXPERIMENTAL
Intervention: Laparoscopic radical hysterectomy (LRH)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Abdominal radical hysterectomy (ARH)
Number of subjects: 30
Study: 21413691

Group type: COMPARATOR
Intervention: Standardized curcuminoid mixture
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lecithin formulation (Meriva)
Number of subjects: 0
Study: 19109001

Group type: EXPERIMENTAL
Intervention: Lemon juice
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Lemon grass (Cymbopogon citratus)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Gentian violet aqueous solution 0.5%
Number of subjects: 90
Study: 17683329

Group type: EXPERIMENTAL
Intervention: 27-gauge needle
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 30-gauge needle
Number of subjects: 95
Study: 15074737

Group type: EXPERIMENTAL
Intervention: Flexible Ralstron applicator
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Rigid Rotterdam applicator
Number of subjects: 50

Group type: COMPARATOR
Intervention: Both applicators
Number of subjects: 50
Study: 11506055

Group type: EXPERIMENTAL
Intervention: 15 g AG per day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 30 g AG per day
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: AG (15 g and 30 g)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control beverage
Number of subjects: 20
Study: 9760014

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate inhaled by Rotahaler (Becotide Rotacaps)
Number of subjects: 182

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate inhaled by Cyclohaler (Beclomethasone Cyclocaps)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Rescue medication use in Rotahaler group
Number of subjects: 182

Group type: COMPARATOR
Intervention: Withdrawal from study
Number of subjects: 182
Study: 8583466

Group type: EXPERIMENTAL
Intervention: Moexipril monotherapy (7.5 or 15 mg once daily)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Moexipril combined with hydrochlorothiazide (7.5 or 15 mg daily with 25 mg hydrochlorothiazide)
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: Moexipril monotherapy or combination therapy
Number of subjects: 172
Study: 2515971

Group type: EXPERIMENTAL
Intervention: Clonidine administration
Number of subjects: 24

Group type: COMPARATOR
Intervention: No drug
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diabetics with neuropathy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Diabetics without neuropathy
Number of subjects: 24

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 24
Study: 872912

Group type: EXPERIMENTAL
Intervention: Complementary rules
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Symmetrical rules
Number of subjects: 48
Study: 29419533

Group type: EXPERIMENTAL
Intervention: Ergocalciferol 50,000 IU once weekly for 8 weeks then once monthly for 4 months
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Ergocalciferol 50,000 IU
Number of subjects: 30
Study: 28116776

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 5 mg
Number of subjects: 461

Group type: EXPERIMENTAL
Intervention: Ertugliflozin 15 mg
Number of subjects: 461
Study: 26147153

Group type: EXPERIMENTAL
Intervention: HBX (HYBENX® Oral Tissue Decontaminant™) in association with sub‐gingival ultrasonic debridement (UD)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: HBX (HYBENX® Oral Tissue Decontaminant™) as monotherapy
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Combined HBX-UD treatment
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group (UD only)
Number of subjects: 16
Study: 26182818

Group type: EXPERIMENTAL
Intervention: Mindfulness-based Stress Reduction (MBSR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 60
Study: 22449144

Group type: EXPERIMENTAL
Intervention: SINA group (step 1 for ACT scores >= 20, step 2 for scores 16-19, step 3 for scores < 16)
Number of subjects: 90

Group type: COMPARATOR
Intervention: GINA group (step 2 for persistent asthma symptoms, step 3 for severely uncontrolled disease)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: SINA group
Number of subjects: 90

Group type: COMPARATOR
Intervention: GINA group
Number of subjects: 90
Study: 19325200

Group type: EXPERIMENTAL
Intervention: RaCe Rotary Instruments
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: FlexMaster Rotary Instruments
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: ProFile Rotary Instruments
Number of subjects: 84
Study: 17328819

Group type: EXPERIMENTAL
Intervention: Garlic group (400 mg garlic, 1 mg allicin, twice daily)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Anethum group (650 mg, twice daily)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 150
Study: 15167450

Group type: EXPERIMENTAL
Intervention: Irbesartan (an inhibitor of angiotensin II type 1 (AT1) receptors)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (diuretic)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Healthy individuals (control group)
Number of subjects: 40
Study: 11293555

Group type: EXPERIMENTAL
Intervention: Celecoxib 100 mg BID
Number of subjects: 718

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg QD
Number of subjects: 718

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 718
Study: 9658786

Group type: EXPERIMENTAL
Intervention: General Anesthesia (GA)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia (SA)
Number of subjects: 60
Study: 7972803

Group type: EXPERIMENTAL
Intervention: Injection into the splenic artery (n=34)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Injection into the superior mesenteric artery (SMA) (n=37)
Number of subjects: 71
Study: 2757903

Group type: EXPERIMENTAL
Intervention: Vigabatrin
Number of subjects: 254
Study: 31692613

Group type: EXPERIMENTAL
Intervention: Mifepristone followed by Misoprostol (Group M, n=60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Mifepristone followed by Ethacridine Lactate and Oxytocin (Group E, n=60)
Number of subjects: 120
Study: 27942720

Group type: EXPERIMENTAL
Intervention: safinamide
Number of subjects: 549

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 549
Study: 26505870

Group type: EXPERIMENTAL
Intervention: ESCAPE‐DD curriculum
Number of subjects: 58

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 58
Study: 24491463

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium (MgSO4 50mg/kg in 100 mL of normal saline over 15 min before anesthesia induction, followed by an infusion of 15 mg/kg/hour)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Intravenous magnesium
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 50
Study: 21689089

Group type: EXPERIMENTAL
Intervention: NT-proBNP level ≥160ng/l
Number of subjects: 758
Study: 18471448

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation training program (3 months, exercise intensity 55% to 70% of peak VO2)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Nontraining group (usual lifestyle)
Number of subjects: 39
Study: 16503677

Group type: EXPERIMENTAL
Intervention: High-CHO diet (6.5 g CHO kg body mass(‐1))
Number of subjects: 8

Group type: COMPARATOR
Intervention: Moderate-CHO diet (4.4 g CHO kg body mass(‐1))
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: High-CHO diet
Number of subjects: 8

Group type: COMPARATOR
Intervention: Moderate-CHO diet
Number of subjects: 8
Study: 12757968

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral treatment group
Number of subjects: 76

Group type: COMPARATOR
Intervention: Treatment-as-usual group
Number of subjects: 76
Study: 10974381

Group type: EXPERIMENTAL
Intervention: External beam radiotherapy (XRT)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Endobronchial brachytherapy (EBT)
Number of subjects: 99

Group type: COMPARATOR
Intervention: Clinician assessments
Number of subjects: 99
Study: 9194044

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tricyclic antidepressants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unmedicated patients
Number of subjects: 0
Study: 8118749

Group type: EXPERIMENTAL
Intervention: Pamidronate (APD)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: T3 (100 micrograms/day)
Number of subjects: 22
Study: 3136210

Group type: EXPERIMENTAL
Intervention: J5-IVIG
Number of subjects: 100

Group type: COMPARATOR
Intervention: IVIG
Number of subjects: 100
Study: 30900008

Group type: EXPERIMENTAL
Intervention: Phendimetrazine 210 mg
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Cocaine (0, 20, 40, and 80 mg intranasal)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Phendimetrazine
Number of subjects: 29
Study: 28468840

Group type: EXPERIMENTAL
Intervention: Intra-arterial treatment
Number of subjects: 760
Study: 26619143

Group type: EXPERIMENTAL
Intervention: Systematic Community Engagement (SCE) interventions in intervention facilities
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control facilities (no SCE intervention)
Number of subjects: 64
Study: 23314228

Group type: EXPERIMENTAL
Intervention: Transobturator sling surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Surgery alone (control)
Number of subjects: 100
Study: 21262413

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) - three manualized sessions including one physical activity exposure session
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care from general practitioner
Number of subjects: 40
Study: 18655472

Group type: EXPERIMENTAL
Intervention: Low-protein diet (0.6 g protein/kg/day) balanced by high-calorie mix containing protein SUPRO 760 or ketosteril for 24-48 months
Number of subjects: 200
Study: 17217711

Group type: EXPERIMENTAL
Intervention: Losartan 50 mg
Number of subjects: 351

Group type: EXPERIMENTAL
Intervention: Irbesartan 150 mg
Number of subjects: 351

Group type: COMPARATOR
Intervention: Losartan 50 mg and Irbesartan 150 mg
Number of subjects: 351
Study: 12662006

Group type: EXPERIMENTAL
Intervention: Arginine
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 11147940

Group type: EXPERIMENTAL
Intervention: Multiband ligation
Number of subjects: 45

Group type: COMPARATOR
Intervention: Conventional ligation
Number of subjects: 45
Study: 9378192

Group type: EXPERIMENTAL
Intervention: Echocardiographic guidance during endomyocardial biopsy (EMB)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Fluoroscopic guidance during endomyocardial biopsy (EMB)
Number of subjects: 38
Study: 8097114

Group type: EXPERIMENTAL
Intervention: Raclopride 2 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Raclopride 6 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Raclopride 12 mg
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Raclopride (all doses)
Number of subjects: 17
Study: 2880747

Group type: EXPERIMENTAL
Intervention: Theophylline (plasma concentration 25-45 mumol/l)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Theophylline (plasma concentration 50-85 mumol/l)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (0 mumol/l)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Theophylline (various concentrations)
Number of subjects: 20
Study: 31599019

Group type: EXPERIMENTAL
Intervention: l-carnitine
Number of subjects: 208

Group type: COMPARATOR
Intervention: usual intake (control)
Number of subjects: 208
Study: 29473237

Group type: EXPERIMENTAL
Intervention: Healthy Dads Healthy Kids (HDHK) intervention
Number of subjects: 93
Study: 26876690

Group type: EXPERIMENTAL
Intervention: BCI-FES
Number of subjects: 20

Group type: COMPARATOR
Intervention: FES
Number of subjects: 20

Group type: COMPARATOR
Intervention: BCI-FES vs FES
Number of subjects: 20
Study: 25639126

Group type: EXPERIMENTAL
Intervention: Nutrition education promoting consumption of khichuri
Number of subjects: 300

Group type: COMPARATOR
Intervention: Routine services from health facilities
Number of subjects: 300
Study: 23896317

Group type: EXPERIMENTAL
Intervention: High-frequency (HF) rTMS treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 20
Study: 20131046

Group type: EXPERIMENTAL
Intervention: Vertical parallel arrays of short line segments
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Horizontal parallel arrays of short line segments
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Concentric arrays of short line segments
Number of subjects: 6

Group type: COMPARATOR
Intervention: Randomly oriented segments
Number of subjects: 6
Study: 19037765

Group type: EXPERIMENTAL
Intervention: Menstrual pad with emollient-treated surface layer and polymeric absorbent foam core
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional marketed pads
Number of subjects: 0
Study: 16176526

Group type: EXPERIMENTAL
Intervention: J-shaped leads (JL)
Number of subjects: 208

Group type: COMPARATOR
Intervention: Straight leads (SL)
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Both groups (JL and SL)
Number of subjects: 208
Study: 12509549

Group type: EXPERIMENTAL
Intervention: Videotape intervention (videotape, PCC pamphlet, and PCC stickers)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Regularly scheduled WIC class (control group)
Number of subjects: 289
Study: 10442725

Group type: EXPERIMENTAL
Intervention: Silicon expander (SE)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Translational recession (TR)
Number of subjects: 16
Study: 8692630

Group type: EXPERIMENTAL
Intervention: hGH (0.2 IU/kg/day subcutaneously to a maximum of 16 IU/day) for 7 days
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 1775263

Group type: EXPERIMENTAL
Intervention: Haemodialysis with desferrioxamine (1 g intravenously 24‐40 h before dialysis); n = 28
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Haemofiltration with desferrioxamine (1 g intravenously 24‐40 h before haemofiltration); n = 36
Number of subjects: 64
Study: 6675065

Group type: EXPERIMENTAL
Intervention: 0.8% prilocaine (4 mg/kg body weight)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 1.5% prilocaine (4 mg/kg body weight)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2% prilocaine (4 mg/kg body weight)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.8% prilocaine
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: 2% prilocaine
Number of subjects: 20
Study: 31809905

Group type: EXPERIMENTAL
Intervention: 5mg zopiclone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 10mg zopiclone
Number of subjects: 16

Group type: COMPARATOR
Intervention: Both dosing groups
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: N-desmethylzopiclone
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: zopiclone N-oxide
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 5mm hair segments
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Sampling 1-2 months after exposure
Number of subjects: 16
Study: 31277533

Group type: EXPERIMENTAL
Intervention: 3D printing brace after small splint external fixation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group with small splint external fixation
Number of subjects: 60
Study: 28527873

Group type: EXPERIMENTAL
Intervention: LED light handle
Number of subjects: 42

Group type: COMPARATOR
Intervention: Xenon halogen
Number of subjects: 42
Study: 27274152

Group type: EXPERIMENTAL
Intervention: Dental health education by trained schoolteachers at intervals of 15 days, 1 month, and 3 months
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Dental health education by dental professionals at intervals of 15 days, 1 month, and 3 months
Number of subjects: 71

Group type: COMPARATOR
Intervention: No further dental health education (control group)
Number of subjects: 71
Study: 25057211

Group type: COMPARATOR
Intervention: fMRI investigation of the extrastriate body area (EBA) in blind and sighted subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sensitivity of the superior part of the EBA and supramarginal gyrus
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sensitivity of the inferior part of the EBA
Number of subjects: 0
Study: 21365326

Group type: EXPERIMENTAL
Intervention: A2A2 genotype of the PIN3 (+16 bp) polymorphism in patients treated with chemotherapy without anthracycline
Number of subjects: 94

Group type: COMPARATOR
Intervention: TP53 polymorphisms, Arg72Pro and PIN3 (+16 bp)
Number of subjects: 94

Group type: COMPARATOR
Intervention: TNM stage
Number of subjects: 94

Group type: COMPARATOR
Intervention: Grade
Number of subjects: 94
Study: 20675336

Group type: EXPERIMENTAL
Intervention: Cefazolin
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Cefazolin + Vancomycin
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Cefazolin + Daptomycin
Number of subjects: 169
Study: 17404368

Group type: COMPARATOR
Intervention: High-dose chemotherapy (HDC) with autologous hematopoietic progenitor cell support (AHPCS)
Number of subjects: 536

Group type: EXPERIMENTAL
Intervention: Dose-dense and dose-escalated chemotherapy with doxorubicin, paclitaxel, and cyclophosphamide
Number of subjects: 536
Study: 15827104

Group type: EXPERIMENTAL
Intervention: Intravenous alendronate (ALN) at a dose of 125 mcg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral alendronate (ALN) 35 mg for patients weighing less than 40 kg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oral alendronate (ALN) 70 mg for patients weighing 40 kg or more
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Adverse experiences from single-dose ALN
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Laboratory safety monitoring
Number of subjects: 24
Study: 12905641

Group type: EXPERIMENTAL
Intervention: Alendronate 10 mg/d
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 56
Study: 9877516

Group type: EXPERIMENTAL
Intervention: Mineral salt (MS) group
Number of subjects: 21

Group type: COMPARATOR
Intervention: Regular salt (RS) group
Number of subjects: 21
Study: 8934956

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 2529370

Group type: EXPERIMENTAL
Intervention: Atrial natriuretic peptide (ANP) infusion at 1.2 pmol kg‐1 min‐1
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Head-down tilt
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 8
Study: 385398

Group type: EXPERIMENTAL
Intervention: Diflunisal 500 mg daily
Number of subjects: 35

Group type: COMPARATOR
Intervention: Ibuprofen 1200 mg daily
Number of subjects: 35
Study: 31843633

Group type: EXPERIMENTAL
Intervention: Drainless group (n=50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Drainage group (n=50)
Number of subjects: 100
Study: 31813281

Group type: EXPERIMENTAL
Intervention: Valsartan
Number of subjects: 178

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 178
Study: 26853191

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction (MBSR)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 60
Study: 26575256

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 1200 mg/day
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Eslicarbazepine acetate (ESL) 800 mg/day
Number of subjects: 547

Group type: EXPERIMENTAL
Intervention: Combined ESL arms (800 and 1200 mg/day)
Number of subjects: 547

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 547
Study: 23021320

Group type: EXPERIMENTAL
Intervention: Active TMS (N=155)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Sham TMS (N=146)
Number of subjects: 301
Study: 20736382

Group type: EXPERIMENTAL
Intervention: Tailored Pro‐Self(©) exercise during and after chemotherapy
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care (no Pro‐Self)
Number of subjects: 100
Study: 19359920

Group type: EXPERIMENTAL
Intervention: Continuous bupivacaine infusion through thoracic epidural (TEA)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Continuous bupivacaine infusion through thoracic paravertebral block (TPVB)
Number of subjects: 30

Group type: COMPARATOR
Intervention: TEA
Number of subjects: 30

Group type: COMPARATOR
Intervention: TPVB
Number of subjects: 30
Study: 16309809

Group type: EXPERIMENTAL
Intervention: 375 mg of E. amoenum aqueous extract
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 15564180

Group type: EXPERIMENTAL
Intervention: Sentinel lymph node biopsy (SLNB) alone
Number of subjects: 1012

Group type: COMPARATOR
Intervention: Axillary clearance (AC) plus SLNB
Number of subjects: 1012